Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: A report from the japanese pediatric leukemia/lymphoma study group

Daisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, Akiko Moriya Saito, Kazuko Kudo, Takashi Taga, Shotaro Iwamoto, Akira Shimada, Kiminori Terui, Hiroshi Moritake, Akitoshi Kinoshita, Hiroyuki Takahashi, Hideki Nakayama, Nobutaka Kiyokawa, Keiichi Isoyama, Shuki Mizutani, Junichi Hara, Keizo Horibe, Tatsutoshi Nakahata, Souichi Adachi